NHS National Framework for Transition products commencing 1 October 2024
£16,224,000
Contract Details
- Tender Value
- £41,320,000
- Stage
- Awarded
- Published
- Awarded
Timeline
Description
Project title: NHS National Framework for Transition products commencing 1 October 2024 Offer reference number: CM/TNS/24/5712 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) CM/TNS/24/5712/02 - Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Related Contracts
From This Buyer
From This Supplier
- NHS London Branded Medicines - Tranche B - September 2023
£231,083,000 ·
- NHS Framework for the North of England, Branded Medicine
£238,913,892 ·
- NHS Framework Agreement for Branded medicines - National
£526,000,000 ·
In This Category
Ref: 5ce17d64-f30a-47b5-916f-e45e3f31e0da-795000 · Sourced from Contracts Finder
View source notice